The role of RhoA kinase inhibition in human placenta-derived multipotent cells on neural phenotype and cell survival

Biomaterials

Volumn 34, Issue 13, 2013, Pages 3223-3230

  Wang, Chih Hsiang ^a,b   Wu, Chia Ching ^c   Hsu, Shan Hui ^d   Liou, Jun Yang ^e   Li, Yu Wei ^b   Wu, Kenneth K ^e   Lai, Yiu Kay ^a,g   Yen, B Linju ^b,f  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b National Health Research Institutes NHRI   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f Department of Obstetrics/Gynecology   (Taiwan)

^g NONE   (Taiwan)

Author keywords

Cytoskeleton; Multipotent mesenchymal stem cells; Neural differentiation; Placenta; Rho kinase (ROCK); Y 27632

Indexed keywords

CELL CULTURE; DISEASE CONTROL; ENZYMES; ROCKS;

CYTOSKELETONS; MESENCHYMAL STEM CELL; NEURAL DIFFERENTIATIONS; PLACENTA; RHO KINASE (ROCK); Y-27632;

STEM CELLS;

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; MESODERMAL GROWTH FACTOR; MICROTUBULE ASSOCIATED PROTEIN 2; MYOSIN; NESTIN; PROTEIN KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RNA;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CELL SPECIFICITY; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MESODERM; MULTIPOTENT STEM CELL; NEURAL STEM CELL; PHENOTYPE; PLACENTA DERIVED MULTIPOTENT CELL; PRIORITY JOURNAL;

EID: 84874275277     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.12.034     Document Type: Article

References (35)

1. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
2. Ostenfeld T., Svendsen C.N. Recent advances in stem cell neurobiology. Adv Tech Stand Neurosurg 2003, 28:3-89.
3. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370.
4. Sanchez-Ramos J., Song S., Cardozo-Pelaez F., Hazzi C., Stedeford T., Willing A., et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000, 164:247-256.
5. Rao M.S., Mattson M.P. Stem cells and aging: expanding the possibilities. Mech Ageing Dev 2001, 122:713-734.
6. Yen B.L., Huang H.I., Chien C.C., Jui H.Y., Ko B.S., Yao M., et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005, 23:3-9.
7. Yen B.L., Chien C.C., Chen Y.C., Chen J.T., Huang J.S., Lee F.K., et al. Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro. Tissue Eng Part A 2008, 14:9-17.
8. Chang C.J., Yen M.L., Chen Y.C., Chien C.C., Huang H.I., Bai C.H., et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 2006, 24:2466-2477.
9. Liu K.J., Wang C.J., Chang C.J., Hu H.I., Hsu P.J., Wu Y.C., et al. Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell Transplant 2011, 10-11:1721-1730.
10. Brooke G., Cook M., Blair C., Han R., Heazlewood C., Jones B., et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 2007, 18:846-858.
11. Sanchez-Ramos J.R. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 2002, 69:880-893.
12. Ninomiya Y., Adams R., Morriss-Kay G.M., Eto K. Apoptotic cell death in neuronal differentiation of P19 EC cells: cell death follows reentry into S phase. J Cell Physiol 1997, 172:25-35.
13. Liao J.K., Seto M., Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 2007, 50:17-24.
14. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004, 6:483-495.
15. Pacary E., Legros H., Valable S., Duchatelle P., Lecocq M., Petit E., et al. Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J Cell Sci 2006, 119:2667-2678.
16. Riento K., Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003, 4:446-456.
17. Strauss S. Geron trial resumes, but standards for stem cell trials remain elusive. Nat Biotechnol 2010, 28:989-990.
18. Keirstead H.S. Stem cell transplantation into the central nervous system and the control of differentiation. J Neurosci Res 2001, 63:233-236.
19. Schwartz P.H., Brick D.J., Stover A.E., Loring J.F., Muller F.J. Differentiation of neural lineage cells from human pluripotent stem cells. Methods 2008, 45:142-158.
20. Liu Y., Song Z., Zhao Y., Qin H., Cai J., Zhang H., et al. A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun 2006, 346:131-139.
21. Neal B.S., Sparber S.B. Long-term effects of neonatal exposure to isobutylmethylxanthine. I. Retardation of learning with antagonism by mianserin. Psychopharmacology (Berl) 1991, 103:388-397.
22. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
23. Luo L. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000, 1:173-180.
24. Spiegelman B.M., Ginty C.A. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell 1983, 35:657-666.
25. Carvalho R.S., Schaffer J.L., Gerstenfeld L.C. Osteoblasts induce osteopontin expression in response to attachment on fibronectin: demonstration of a common role for integrin receptors in the signal transduction processes of cell attachment and mechanical stimulation. J Cell Biochem 1998, 70:376-390.
26. Chklovskii D.B. Synaptic connectivity and neuronal morphology: two sides of the same coin. Neuron 2004, 43:609-617.
27. Da Silva J.S., Medina M., Zuliani C., Di Nardo A., Witke W., Dotti C.G. RhoA/ROCK regulation of neuritogenesis via profilin IIa-mediated control of actin stability. J Cell Biol 2003, 162:1267-1279.
28. Lehmann M., Fournier A., Selles-Navarro I., Dergham P., Sebok A., Leclerc N., et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 1999, 19:7537-7547.
29. Pacary E., Tixier E., Coulet F., Roussel S., Petit E., Bernaudin M. Crosstalk between HIF-1 and ROCK pathways in neuronal differentiation of mesenchymal stem cells, neurospheres and in PC12 neurite outgrowth. Mol Cell Neurosci 2007, 35:409-423.
30. Lawrence D.A., Colinas R.J., Walsh A.C. Influence of oxygen partial pressure on human and mouse myeloid cell line characteristics. Fundam Appl Toxicol 1996, 29:287-293.
31. Chang T.C., Chen Y.C., Yang M.H., Chen C.H., Hsing E.W., Ko B.S., et al. Rho kinases regulate the renewal and neural differentiation of embryonic stem cells in a cell plating density-dependent manner. PLoS One 2012, 5:e9187.
32. Kitani H., Ikeda H., Atsumi T., Watanabe R. Efficiency of neural differentiation of mouse P19 embryonal carcinoma cells is dependent on the seeding density. Cell Transplant 1997, 6:521-525.
33. Lu H., Guo L., Wozniak M.J., Kawazoe N., Tateishi T., Zhang X., et al. Effect of cell density on adipogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2009, 381:322-327.
34. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., Maekawa M., et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000, 57:976-983.
35. Lock F.E., Hotchin N.A. Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation. PLoS One 2009, 4:e8190.